In all, our results concluded that HCP5 is involved in esophageal carcinoma radiotherapy and knockdown HCP5 enhances the radiosensitivity of esophageal carcinoma by modulating AKT signaling activation. Here, HCP5 is linked to carcinoma of esophagus.